Broadly neutralizing antibodies target the coronavirus fusion peptide
2022 · Science · 263 citations
https://doi.org/10.1126/science.abq3773
M
Meng Yuan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
174
Papers
10.9K
Citations
44
h-index
90
i10-index
Meng Yuan is an academic researcher from Scripps Research Institute. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Monoclonal and Polyclonal Antibodies Research & Animal Virus Infections Studies. The author has an h-index of 44, co-authored 148 publications.
ORCID: 0000-0001-9754-4503Papers by this author
worksBroadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease
2023 · Immunity · 157 citations
https://doi.org/10.1016/j.immuni.2023.02.005
A large-scale systematic survey reveals recurring molecular features of public antibody responses to SARS-CoV-2
2022 · Immunity · 116 citations
https://doi.org/10.1016/j.immuni.2022.03.019
Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain
2021 · Nature Communications · 76 citations
https://doi.org/10.1038/s41467-021-24123-7
Allosteric pyruvate kinase-based “logic gate” synergistically senses energy and sugar levels in Mycobacterium tuberculosis
2017 · Nature Communications · 64 citations
https://doi.org/10.1038/s41467-017-02086-y
Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses
2022 · Cell Host & Microbe · 62 citations
https://doi.org/10.1016/j.chom.2022.10.010
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat